Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Suboxone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Suboxone 8mg/2mg sublingual tablets
0410030B0BBAAAA
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 384 |
|
Suboxone 2mg/500microgram sublingual tablets
0410030B0BBABAB
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 349 |
|
Suboxone 2mg/500microgram sublingual films
0410030B0BBADAD
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 8 |
|
Suboxone 8mg/2mg sublingual films
0410030B0BBAEAE
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 6 |
|
Suboxone 16mg/4mg sublingual tablets
0410030B0BBACAC
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.